Quoin Pharmaceuticals (QNRX) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free QNRX Stock Alerts $0.78 +0.08 (+11.48%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | finance.yahoo.comQNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 ApprovalsMay 9, 2024 | msn.comQuoin Pharmaceuticals Non-GAAP EPS of -$1.11 misses by $0.70May 9, 2024 | finance.yahoo.comQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsMay 2, 2024 | globenewswire.comQuoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024March 16, 2024 | seekingalpha.comQuoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | markets.businessinsider.comMaxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To KnowMarch 15, 2024 | finance.yahoo.comQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | finanznachrichten.deQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsMarch 14, 2024 | benzinga.comQuoin Pharmaceuticals: Q4 Earnings InsightsMarch 13, 2024 | globenewswire.comQuoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsMarch 7, 2024 | msn.comWhy Quoin Pharmaceuticals (QNRX) Shares Are NosedivingMarch 7, 2024 | globenewswire.comQuoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ETMarch 6, 2024 | finance.yahoo.comQNRX: Potential Pool of Study Participants Expands; Financial Position StrengthsMarch 5, 2024 | seekingalpha.comQTI, RNLX and MTC among pre-market losersMarch 5, 2024 | msn.comWhy Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?March 5, 2024 | finance.yahoo.comQuoin Pharmaceuticals Announces Pricing of $6.5 Million Public OfferingMarch 4, 2024 | marketwatch.comQuoin Pharma Shares Double After FDA Grants Clearance for Teens in QRX003 TrialMarch 4, 2024 | markets.businessinsider.comQuoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003March 4, 2024 | msn.comWhy Quoin Pharmaceutical Stock Is SoaringDecember 15, 2023 | markets.businessinsider.comBuy Rating for Quoin Pharmaceuticals Amid Promising Netherton Syndrome Drug ProspectsDecember 13, 2023 | morningstar.comQuoin Pharmaceuticals Ltd ADRDecember 13, 2023 | finanznachrichten.deQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton SyndromeDecember 13, 2023 | markets.businessinsider.comFDA Clears Quoin Pharma's Protocol Amendments For QRX003 Trials In Netherton Syndrome TreatmentNovember 13, 2023 | finance.yahoo.comQNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory ApprovalNovember 10, 2023 | finance.yahoo.comQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | morningstar.comQuoin Pharmaceuticals Ltd ADR QNRXNovember 9, 2023 | msn.comQuoin Pharmaceuticals GAAP EPS of -$7.61 misses by $4.89November 8, 2023 | finance.yahoo.comQuoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 7, 2023 | benzinga.comPreview: Quoin Pharmaceuticals's EarningsNovember 3, 2023 | finance.yahoo.comQuoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ETOctober 24, 2023 | finance.yahoo.comQuoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton SyndromeOctober 24, 2023 | finance.yahoo.comREPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton SyndromeOctober 2, 2023 | finance.yahoo.comQNRX: Positive Early Clinical Data, Moving QRX003 Through Multiple TrialsAugust 9, 2023 | finance.yahoo.comQuoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for ShareholdersAugust 3, 2023 | msn.comQuoin Pharmaceuticals Ltd - ADR (QNRX) Price Target Increased by 1423.07% to 134.64July 27, 2023 | finance.yahoo.comQuoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ETJuly 21, 2023 | benzinga.comWhat's Going On With Quoin Pharmaceuticals (QNRX) Stock Today?July 21, 2023 | marketbeat.comTrading was temporarily halted for "QNRX" at 10:07 AM with a stated reason of "LULD pause."July 21, 2023 | marketbeat.comTrading was temporarily halted for "QNRX" at 09:07 AM with a stated reason of "LULD pause."July 21, 2023 | marketbeat.comTrading was temporarily halted for "QNRX" at 09:07 AM with a stated reason of "LULD pause."July 21, 2023 | marketbeat.comTrading was temporarily halted for "QNRX" at 09:07 AM with a stated reason of "LULD pause."July 18, 2023 | marketbeat.comTrading was temporarily halted for "QNRX" at 12:07 PM with a stated reason of "LULD pause."July 17, 2023 | msn.comWhy Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?July 17, 2023 | msn.comWhy Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?May 24, 2023 | finance.yahoo.comQuoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical TrialMay 12, 2023 | finanznachrichten.deQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial ResultsMay 8, 2023 | finance.yahoo.comQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial ResultsMay 5, 2023 | msn.comA Preview Of Quoin Pharmaceuticals's EarningsMay 2, 2023 | finance.yahoo.comQuoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… QNRX Media Mentions By Week QNRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QNRX News Sentiment▼1.430.76▲Average Medical News Sentiment QNRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QNRX Articles This Week▼21▲QNRX Articles Average Week Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GRTX News Today MNPR News Today MBRX News Today KTRA News Today ERNA News Today AEZS News Today CMMB News Today ABVC News Today UPC News Today NCNA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:QNRX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
